These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12833655)

  • 41. Aplidin PharmaMar.
    Yao L
    IDrugs; 2003 Mar; 6(3):246-50. PubMed ID: 12789614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pralnacasan (vertex pharmaceuticals).
    Siegmund B; Zeitz M
    IDrugs; 2003 Feb; 6(2):154-8. PubMed ID: 12789619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in the treatment of early rheumatoid arthritis.
    Vital EM; Emery P
    Am Fam Physician; 2005 Sep; 72(6):1002, 1004. PubMed ID: 16190499
    [No Abstract]   [Full Text] [Related]  

  • 44. ONT-093 (Ontogen).
    Mistry P; Folkes A
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1666-71. PubMed ID: 12476971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New perspectives in the treatment of rheumatoid arthritis].
    Martín Alcalde E; Cantero Blanco S; Sánchez García FJ; Gómez Castillo JJ
    Farm Hosp; 2003; 27(6):360-70. PubMed ID: 14974882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 47. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 48. Interleukin-18 and the treatment of rheumatoid arthritis.
    Dinarello CA
    Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra).
    Settas LD; Tsimirikas G; Vosvotekas G; Triantafyllidou E; Nicolaides P
    J Clin Rheumatol; 2007 Aug; 13(4):219-20. PubMed ID: 17762459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal testosterone gel (Cellegy).
    McGriff-Lee NJ
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1629-32. PubMed ID: 12476964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.
    Jüni P; Dieppe P
    Age Ageing; 2004 Mar; 33(2):100-4. PubMed ID: 14960422
    [No Abstract]   [Full Text] [Related]  

  • 52. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 53. TAK-677 (Dainippon/Takeda).
    Francke S
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1624-8. PubMed ID: 12476963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokines and drugs workshop.
    Hom JT; Simon PL
    Agents Actions Suppl; 1991; 35():147-50. PubMed ID: 1781419
    [No Abstract]   [Full Text] [Related]  

  • 55. [Relation between rheumatoid arthritis and interleukin-1].
    Zhang XL; Liu TD
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):252-4. PubMed ID: 12532792
    [No Abstract]   [Full Text] [Related]  

  • 56. Sarilumab for the treatment of rheumatoid arthritis.
    Cooper S
    Immunotherapy; 2016; 8(3):249-50. PubMed ID: 26860742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-(5-Alkyl-4-hydroxy-3-methoxy-1-naphthalenyl)-2-methyl-2-propenoic acids as orally active inhibitors of IL-1 generation.
    Tanaka M; Chiba K; Okita M; Kaneko T; Tagami K; Hibi S; Okamoto Y; Shirota H; Goto M; Sakurai H
    J Med Chem; 1991 Aug; 34(8):2647-9. PubMed ID: 1875355
    [No Abstract]   [Full Text] [Related]  

  • 58. Pixantrone (Novuspharma).
    Borchmann P; Reiser M
    IDrugs; 2003 May; 6(5):486-90. PubMed ID: 12789604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ASAS recommendations for variables to be collected in clinical trials/epidemiological studies of spondyloarthritis.
    Dougados M; Braun J; Vargas RB; Gossec L; Maksymowych W; Sieper J; van der Heijde D
    Ann Rheum Dis; 2012 Jun; 71(6):1103-4. PubMed ID: 22294624
    [No Abstract]   [Full Text] [Related]  

  • 60. The optimum time for drug licensing.
    Kalamas J; Pinkus G
    Nat Rev Drug Discov; 2003 Sep; 2(9):691-2. PubMed ID: 12953694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.